Genedrive (GB:GDR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Genedrive PLC has released its 2024 Annual Report and announced the upcoming Annual General Meeting on December 30, 2024. The company, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 and CYP2C19 ID Kits, enhancing personalized medicine and improving patient outcomes in emergency care. The company is focused on growth through market expansion and strategic acquisitions.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.
